Skip to content
Boca Raton City Online – Lifestyle
Author:
CURIS, INC.
Curis Doses First Five Patients in TakeAim CLL Study
July 30, 2026
Curis Announces Positive Emavusertib Update
July 22, 2026
Curis Consents First Six Patients in TakeAim CLL Study
July 6, 2026
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
June 26, 2026
Curis Provides First Quarter 2026 Business Update
May 12, 2026
Curis Provides Fourth Quarter 2025 Business Update
March 19, 2026
Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026
March 12, 2026